N-arylalkyl pseudopeptide inhibitors of farnesyltransferase

被引:24
作者
deSolms, SJ [1 ]
Giuliani, EA
Graham, SL
Koblan, KS
Kohl, NE
Mosser, SD
Oliff, AI
Pompliano, DL
Rands, E
Scholz, TH
Wiscount, CM
Gibbs, JB
Smith, RL
机构
[1] Merck Res Labs, Dept Med Chem, W Point, PA 19486 USA
[2] Merck Res Labs, Dept Canc Res, W Point, PA 19486 USA
关键词
D O I
10.1021/jm9800907
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Inhibitors of Ras protein farnesyltransferase are described which are reduced pseudopeptides related to the C-terminal tetrapeptide of the Ras protein that signals farnesylation. Reduction of the carbonyl groups linking the first three residues of the tetrapeptide leads to active inhibitors which are chemically unstable. Stability can he restored by alkylating the central amine of the tetrapeptide. Studies of the SAR of these alkylated pseudopeptides with concomitant modification of the side chain of the third residue led to 2(S)-(2(S)-{[2(S)-(2(R)-amino-3-mercaptopropylamino)-3-(S)-methylpentyl]naphthalen-1-ylmethylamino}acetylamino)-4-methylsulfanylbutyric acid (11), a subnanomolar inhibitor. The methyl ester (10) of this compound exhibited submicromolar activity in the processing assay and selectively inhibited anchorage-independent growth of Rat1 cells transformed by v-ras at 2.5-5 mu M.
引用
收藏
页码:2651 / 2656
页数:6
相关论文
共 19 条
[1]  
BOS JL, 1989, CANCER RES, V49, P4682
[2]   TETRAPEPTIDE INHIBITORS OF PROTEIN FARNESYLTRANSFERASE - AMINO-TERMINAL SUBSTITUTION IN PHENYLALANINE-CONTAINING TETRAPEPTIDES RESTORES FARNESYLATION [J].
BROWN, MS ;
GOLDSTEIN, JL ;
PARIS, KJ ;
BURNIER, JP ;
MARSTERS, JC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (17) :8313-8316
[3]   ENZYMATIC MODIFICATION OF PROTEINS WITH A GERANYLGERANYL ISOPRENOID [J].
CASEY, PJ ;
THISSEN, JA ;
MOOMAW, JF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (19) :8631-8635
[4]  
FIENGOLD AA, 1991, P NATL ACAD SCI USA, V88, P4448
[5]  
GOLDSTEIN JL, 1991, J BIOL CHEM, V266, P15575
[6]   PSEUDOPEPTIDE INHIBITORS OF RAS FARNESYL-PROTEIN TRANSFERASE [J].
GRAHAM, SL ;
DESOLMS, SJ ;
GIULIANI, EA ;
KOHL, NE ;
MOSSER, SD ;
OLIFF, AI ;
POMPLIANO, DL ;
RANDS, E ;
BRESLIN, MJ ;
DEANA, AA ;
GARSKY, VM ;
SCHOLZ, TH ;
GIBBS, JB ;
SMITH, RL .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (06) :725-732
[7]   SELECTIVE-INHIBITION OF RAS-DEPENDENT TRANSFORMATION BY A FARNESYLTRANSFERASE INHIBITOR [J].
KOHL, NE ;
MOSSER, SD ;
DESOLMS, SJ ;
GIULIANI, EA ;
POMPLIANO, DL ;
GRAHAM, SL ;
SMITH, RL ;
SCOLNICK, EM ;
OLIFF, A ;
GIBBS, JB .
SCIENCE, 1993, 260 (5116) :1934-1937
[8]   PEPTIDE-BASED P21(RAS) FARNESYL TRANSFERASE INHIBITORS - SYSTEMATIC MODIFICATION OF THE TETRAPEPTIDE CA(1)A(2)X MOTIF [J].
LEFTHERIS, K ;
KLINE, T ;
NATARAJAN, S ;
DEVIRGILIO, MK ;
CHO, YH ;
PLUSCEC, J ;
RICCA, C ;
ROBINSON, S ;
SEIZINGER, BR ;
MANNE, V ;
MEYERS, CA .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (07) :887-892
[9]   FUNCTION AND REGULATION OF RAS [J].
LOWY, DR ;
WILLUMSEN, BM .
ANNUAL REVIEW OF BIOCHEMISTRY, 1993, 62 :851-891
[10]  
MOORES SL, 1991, J BIOL CHEM, V266, P14603